• Educational resources
  • Events
  • Expert Panel
  • Learning Hub
    Learning Hub
    • EoE Learning Hub
    • Type 2 Asthma Learning Hub
    • Atopic Dermatitis Learning Hub
    • Bullous Pemphigoid Learning Hub
    • COPD Learning Hub
    • Prurigo Nodularis Learning Hub
    • Rhinology Learning Hub
    • Chronic Spontaneous Urticaria Learning Hub
    • Your Catalyst Learning Hub: Advancing Respiratory Treatment Paradigms
    • Your Navigator Learning Hub: Guiding Personalized Patient Journeys
    • Your Steward Learning Hub: Upholding Excellence in Everyday Practice
No matches
  • Cookie policy
  • Privacy policy
  • About us
  • Join ADVENT

ADVENT is a global medical education non-promotional program by Sanofi and Regeneron. This website is intended only for duly authenticated healthcare professionals in Algeria, Argentina, Australia, Austria, Bahrain, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, India, Israel, Italy, Japan, Kuwait, Latvia, Lebanon, Lithuania, Macau, Malaysia, Norway, Oman, Panama, Peru, Poland, Portugal, Qatar, Romania, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sudan, Sweden, Switzerland, Taiwan, Thailand, The Netherlands, Turkey, United Arab Emirates, or the United States of America.

For healthcare professionals in Algeria: Please read the additional Terms of Use.

Sanofi | Regeneron Logo

© 2026 Sanofi and Regeneron Pharmaceuticals, Inc.

All rights reserved.
MAT-US-2305040 v4.0 – P Expiration Date: 10/16/2027

All Rights Reserved.

Sanofi and Regeneron are global leaders in pharmaceutical development, each with a long history of supporting frontline physicians to improve human health and reduce the burden of disease. Driven by the same commitment to patients and their families, Sanofi and Regeneron have partnered to take on type 2 inflammation and the range of chronic conditions in which excessive inflammation plays a role.

Country/region: United StatesChange country/region

Educational Resources

Categories
Dermatology: Prurigo nodularis
  • Atopic dermatitis
  • Bullous pemphigoid
  • Chronic pruritus of unknown origin
  • Chronic spontaneous urticaria
  • Prurigo nodularis
Gastroenterology: 
  • Eosinophilic esophagitis
Pulmonology: 
  • Asthma
  • Chronic obstructive pulmonary disease
  • IL-33
Rhinology: 
  • Chronic rhinosinusitis with nasal polyps
Filters
Topic: 
  • Burden of disease
  • Pathophysiology
  • Guidelines and recommendations
  • Clinical management
  • Co-existing type 2 inflammatory diseases
Format: 
  • Expert Video
  • Podcast
  • Slide presentation
  • Infographic
  • Video animation
  • Interactivity
Length: 
  • Short (<5 minutes)
  • Medium (5-15 minutes)
  • Long (> 15 minutes)
Sort by: Newest
  • Newest
  • Oldest
  • A-Z
  • Z-A
The Type 2 Interface: Unifying AD, CSU, and PN Pathophysiology and Dispelling Common Misconceptions
Dermatology
35 min
expert video

The Type 2 Interface: Unifying AD, CSU, and PN Pathophysiology and Dispelling Common Misconceptions

Challenging Misconceptions for Better Patient Care in AD and PN: Insight into Type 2 Inflammation
Dermatology
34 min
expert video

Challenging Misconceptions for Better Patient Care in AD and PN: Insight into Type 2 Inflammation

Patients With Prurigo Nodularis Have a High Prevalence of Atopic and Non-Atopic Comorbidities​
Dermatology
2 min
expert video

Patients With Prurigo Nodularis Have a High Prevalence of Atopic and Non-Atopic Comorbidities​

Prurigo Nodularis Management Goals: From Itch Control to Improved Quality of Life
Dermatology
2 min
expert video

Prurigo Nodularis Management Goals: From Itch Control to Improved Quality of Life

Prurigo Nodularis Is a Challenging Diagnosis
Dermatology
2 min
expert video

Prurigo Nodularis Is a Challenging Diagnosis

Neuroimmune Dysfunction Is Critical in the Pathophysiology of Prurigo Nodularis
Dermatology
2 min
expert video

Neuroimmune Dysfunction Is Critical in the Pathophysiology of Prurigo Nodularis

ADVENT On-Air Podcast: The Multifaceted Patient Burden and Drivers of Disease in Prurigo Nodularis
Dermatology
20 min
Podcast

ADVENT On-Air Podcast: The Multifaceted Patient Burden and Drivers of Disease in Prurigo Nodularis

Shared and Distinct: The Role of Type 2 Inflammation in Skin Diseases
Dermatology
25 min
expert video

Shared and Distinct: The Role of Type 2 Inflammation in Skin Diseases

Time to Act: Reducing the Impact of Uncontrolled Disease Through Early Intervention
Dermatology
25 min
expert video

Time to Act: Reducing the Impact of Uncontrolled Disease Through Early Intervention

Beyond Signs and Symptoms: Broadening Treatment Goals in Dermatology
Dermatology
25 min
expert video

Beyond Signs and Symptoms: Broadening Treatment Goals in Dermatology

Decoding the Clinical Puzzle: Navigating Diagnostic Complexity Across Inflammatory Skin Diseases
Dermatology
25 min
expert video

Decoding the Clinical Puzzle: Navigating Diagnostic Complexity Across Inflammatory Skin Diseases

Cracking the Code: Diagnosing and Managing Skin Diseases With Type 2 Inflammation
Dermatology
120 min
expert video

Cracking the Code: Diagnosing and Managing Skin Diseases With Type 2 Inflammation

    1234